The North America Genotyping Market would witness market growth of 14.2% CAGR during the forecast period (2022-2028).
Genotyping with single-nucleotide polymorphism identifiers is currently frequently employed in small grain cereal genetic research and breeding. An almost limitless supply of SNP markers has been available due to various technologies such as the scanning of specific portions of the genome, such as transcribed sequences, or the resequencing of variety and lines.
Many samples are now routinely genotyped, especially within the context of genomic selection (GS), employing two distinct approaches such as genotyping-by-sequencing (GBS) and array-based genotyping with predetermined marker sets. Array-based genotyping in tiny grain breeding is evolving from pricey big arrays to smaller, freshly created second-generation arrays. Markers for specific phenotypes, along with high-quality polymorphic markers that are equally dispersed across the chromosomes and have little ascertainment bias, are included in such arrays.
Depending on a log-likelihood proportion calculation, genotype clusters are additionally categorized as non, a medium alert, or high alert. When compared to the concentration of the genotype across the country, alert levels reflect the degree of geographic intensity of cases in the same county or township area. American Indian or Alaska Native people and Native Hawaiian or Other Pacific Islander people continue to have the highest percentages of genotype-clustered cases.
The biggest number of clustered instances were seen among Hispanic or Latino people and non-Hispanic Black or African American people. The number of county-based clusters decreased by 5.3 percent from 1,351 in previous year's cases reported nationally from 2017 to 2019 to 1,280 in 2018–2020.
Universal TB genotyping entails sending at least one isolate to genotyping laboratories for every civilization TB patient in the country. The best understanding of the epidemiology of tuberculosis transmission inside a single TB program's jurisdiction, as well as across the country, would come from universal TB genotyping.
The US market dominated the North America Genotyping Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,381.6 million by 2028. The Canada market is estimated to grow at a CAGR of 16.8% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 15.8% during (2022 - 2028).
Based on Product, the market is segmented into Reagents & Kits, Instruments, and Software & Services. Based on Application, the market is segmented into Diagnostics & Personalized Medicine, Agricultural Biotechnology, Pharmacogenomics, Animal Genetics, and Others. Based on End Use, the market is segmented into Diagnostics & Research Laboratories, Pharmaceutical & Biopharmaceutical Companies, Academic Institutes, and Others. Based on Technology, the market is segmented into PCR, Sequencing, Capillary Electrophoresis, Microarray, Mass Spectrometry, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Genotyping Market is Estimated to reach $30.9 Billion by 2028, at a CAGR of 14.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, and Fluidigm Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Reagents & Kits
- Instruments
- Software & Services
By Application
- Reagents & Kits
- Instruments
- Software & Services
By End Use
- Diagnostics & Research Laboratories
- Pharmaceutical & Biopharmaceutical Companies
- Academic Institutes
- Others
By Technology
- PCR
- Sequencing
- Capillary Electrophoresis
- Microarray
- Mass Spectrometry
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific Group
- Fluidigm Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genotyping Market, by Product
1.4.2 North America Genotyping Market, by Application
1.4.3 North America Genotyping Market, by End Use
1.4.4 North America Genotyping Market, by Technology
1.4.5 North America Genotyping Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Genotyping Market
Chapter 4. North America Genotyping Market by Product
4.1 North America Reagents & Kits Market by Country
4.2 North America Instruments Market by Country
4.3 North America Software & Services Market by Country
Chapter 5. North America Genotyping Market by Application
5.1 North America Diagnostics & Personalized Medicine Market by Country
5.2 North America Agricultural Biotechnology Market by Country
5.3 North America Pharmacogenomics Market by Country
5.4 North America Animal Genetics Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Genotyping Market by End Use
6.1 North America Diagnostics & Research Laboratories Market by Country
6.2 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
6.3 North America Academic Institutes Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Genotyping Market by Technology
7.1 North America PCR Market by Country
7.2 North America Sequencing Market by Country
7.3 North America Capillary Electrophoresis Market by Country
7.4 North America Microarray Market by Country
7.5 North America Mass Spectrometry Market by Country
7.6 North America Others Market by Country
Chapter 8. North America Genotyping Market by Country
8.1 US Genotyping Market
8.1.1 US Genotyping Market by Product
8.1.2 US Genotyping Market by Application
8.1.3 US Genotyping Market by End Use
8.1.4 US Genotyping Market by Technology
8.2 Canada Genotyping Market
8.2.1 Canada Genotyping Market by Product
8.2.2 Canada Genotyping Market by Application
8.2.3 Canada Genotyping Market by End Use
8.2.4 Canada Genotyping Market by Technology
8.3 Mexico Genotyping Market
8.3.1 Mexico Genotyping Market by Product
8.3.2 Mexico Genotyping Market by Application
8.3.3 Mexico Genotyping Market by End Use
8.3.4 Mexico Genotyping Market by Technology
8.4 Rest of North America Genotyping Market
8.4.1 Rest of North America Genotyping Market by Product
8.4.2 Rest of North America Genotyping Market by Application
8.4.3 Rest of North America Genotyping Market by End Use
8.4.4 Rest of North America Genotyping Market by Technology
Chapter 9. Company Profiles
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.1 Recent strategies and developments:
9.1.1.1 Partnerships, Collaborations, and Agreements:
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 Qiagen N.V.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Acquisition and Mergers:
9.9 Fluidigm Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
TABLE 1 North America Genotyping Market, 2018 - 2021, USD Million
TABLE 2 North America Genotyping Market, 2022 - 2028, USD Million
TABLE 3 North America Genotyping Market by Product, 2018 - 2021, USD Million
TABLE 4 North America Genotyping Market by Product, 2022 - 2028, USD Million
TABLE 5 North America Reagents & Kits Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Reagents & Kits Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Instruments Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Software & Services Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Software & Services Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Genotyping Market by Application, 2018 - 2021, USD Million
TABLE 12 North America Genotyping Market by Application, 2022 - 2028, USD Million
TABLE 13 North America Diagnostics & Personalized Medicine Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Diagnostics & Personalized Medicine Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Agricultural Biotechnology Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Agricultural Biotechnology Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Pharmacogenomics Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Pharmacogenomics Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Animal Genetics Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Animal Genetics Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Genotyping Market by End Use, 2018 - 2021, USD Million
TABLE 24 North America Genotyping Market by End Use, 2022 - 2028, USD Million
TABLE 25 North America Diagnostics & Research Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Diagnostics & Research Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Genotyping Market by Technology, 2018 - 2021, USD Million
TABLE 34 North America Genotyping Market by Technology, 2022 - 2028, USD Million
TABLE 35 North America PCR Market by Country, 2018 - 2021, USD Million
TABLE 36 North America PCR Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Sequencing Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Sequencing Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Capillary Electrophoresis Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Capillary Electrophoresis Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Microarray Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Microarray Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Mass Spectrometry Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Mass Spectrometry Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Genotyping Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Genotyping Market by Country, 2022 - 2028, USD Million
TABLE 49 US Genotyping Market, 2018 - 2021, USD Million
TABLE 50 US Genotyping Market, 2022 - 2028, USD Million
TABLE 51 US Genotyping Market by Product, 2018 - 2021, USD Million
TABLE 52 US Genotyping Market by Product, 2022 - 2028, USD Million
TABLE 53 US Genotyping Market by Application, 2018 - 2021, USD Million
TABLE 54 US Genotyping Market by Application, 2022 - 2028, USD Million
TABLE 55 US Genotyping Market by End Use, 2018 - 2021, USD Million
TABLE 56 US Genotyping Market by End Use, 2022 - 2028, USD Million
TABLE 57 US Genotyping Market by Technology, 2018 - 2021, USD Million
TABLE 58 US Genotyping Market by Technology, 2022 - 2028, USD Million
TABLE 59 Canada Genotyping Market, 2018 - 2021, USD Million
TABLE 60 Canada Genotyping Market, 2022 - 2028, USD Million
TABLE 61 Canada Genotyping Market by Product, 2018 - 2021, USD Million
TABLE 62 Canada Genotyping Market by Product, 2022 - 2028, USD Million
TABLE 63 Canada Genotyping Market by Application, 2018 - 2021, USD Million
TABLE 64 Canada Genotyping Market by Application, 2022 - 2028, USD Million
TABLE 65 Canada Genotyping Market by End Use, 2018 - 2021, USD Million
TABLE 66 Canada Genotyping Market by End Use, 2022 - 2028, USD Million
TABLE 67 Canada Genotyping Market by Technology, 2018 - 2021, USD Million
TABLE 68 Canada Genotyping Market by Technology, 2022 - 2028, USD Million
TABLE 69 Mexico Genotyping Market, 2018 - 2021, USD Million
TABLE 70 Mexico Genotyping Market, 2022 - 2028, USD Million
TABLE 71 Mexico Genotyping Market by Product, 2018 - 2021, USD Million
TABLE 72 Mexico Genotyping Market by Product, 2022 - 2028, USD Million
TABLE 73 Mexico Genotyping Market by Application, 2018 - 2021, USD Million
TABLE 74 Mexico Genotyping Market by Application, 2022 - 2028, USD Million
TABLE 75 Mexico Genotyping Market by End Use, 2018 - 2021, USD Million
TABLE 76 Mexico Genotyping Market by End Use, 2022 - 2028, USD Million
TABLE 77 Mexico Genotyping Market by Technology, 2018 - 2021, USD Million
TABLE 78 Mexico Genotyping Market by Technology, 2022 - 2028, USD Million
TABLE 79 Rest of North America Genotyping Market, 2018 - 2021, USD Million
TABLE 80 Rest of North America Genotyping Market, 2022 - 2028, USD Million
TABLE 81 Rest of North America Genotyping Market by Product, 2018 - 2021, USD Million
TABLE 82 Rest of North America Genotyping Market by Product, 2022 - 2028, USD Million
TABLE 83 Rest of North America Genotyping Market by Application, 2018 - 2021, USD Million
TABLE 84 Rest of North America Genotyping Market by Application, 2022 - 2028, USD Million
TABLE 85 Rest of North America Genotyping Market by End Use, 2018 - 2021, USD Million
TABLE 86 Rest of North America Genotyping Market by End Use, 2022 - 2028, USD Million
TABLE 87 Rest of North America Genotyping Market by Technology, 2018 - 2021, USD Million
TABLE 88 Rest of North America Genotyping Market by Technology, 2022 - 2028, USD Million
TABLE 89 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 90 Key Information – Danaher Corporation
TABLE 91 key Information – Agilent Technologies, Inc.
TABLE 92 Key Information – Thermo Fisher Scientific, Inc.
TABLE 93 Key Information – Qiagen N.V.
TABLE 94 key information – Illumina, Inc.
TABLE 95 Key Information – Bio-Rad Laboratories, Inc.
TABLE 96 Key Information – Eurofins Scientific Group
TABLE 97 Key Information – Fluidigm Corporation
List of Figures
FIG 1 Methodology for the research